Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Abroad (travel likely)Recruiting

Conditions

Dry Eye Disease (DED) · Diabete Mellitus · GLP-1 · Ocular Surface · Diabetes Type 2 · Cornea

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

2nd Department of Internal Medicine, Research Institute and Diabetes Center, National and Kapodistrian University of Athens, Athens, GRC., Athens, Greece
Contact: Study coordinator (Vaia Lambadiari) · vlambadiari@gmail.com · (0030)2105832015

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Role of Corneal Nerves in Dry Eye Disease

Dry Eye Disease (DED) · Dry Eye · Dry Eye Sensation

Abroad (travel likely)Recruiting

Olten, Switzerland

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE2, PHASE3

Aliso Viejo, United States · Garden Grove, United States

Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea

Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

Dry Eye Disease (DED)

Abroad (travel likely)RecruitingPHASE4

Andover, United States